AOD-9604 10MG

$80.00

AOD-9604 10MG

Fragmented hGH Peptide for Fat Metabolism Research

Category: Fat Loss & Metabolic Regulation Peptides

AOD9604-10MG | Form: Lyophilized Powder | Purity: ≥ 99% (HPLC Tested)

Product Overview

AOD-9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminal section of human Growth Hormone (hGH). It consists of amino acids 176–191 of the hGH molecule and has been shown in preclinical studies to regulate fat metabolism without affecting insulin sensitivity or inducing growth hormone-related side effects. AOD-9604 promotes lipolysis (breakdown of fat) and inhibits lipogenesis (fat accumulation), making it a widely studied peptide for metabolic and obesity-related research.

Stimulates lipolysis and inhibits lipogenesis via β3-adrenergic receptor activation

AOD-9604 Research Summary

AOD-9604 has been studied extensively for its metabolic activity and selective fat-reducing properties. Unlike full-length hGH, AOD-9604 does not affect blood glucose levels, insulin sensitivity, or growth factor pathways. It is designed to mimic the fat-burning effects of hGH while minimizing potential side effects related to cell proliferation or IGF-1 stimulation.

Key research findings include:

  • Stimulates lipolysis and enhances fat oxidation in adipocytes (Metabolism, 2009).
  • Reduces body fat mass without affecting lean muscle tissue (Obesity Research, 2011).
  • Improves lipid profile and metabolic flexibility in obese models (Front Endocrinol, 2015).
  • Exhibits no proliferative or diabetogenic effects associated with native hGH (Ther Drug Monit, 2018).

These findings suggest that AOD-9604 serves as a promising compound for laboratory exploration of fat metabolism, energy regulation, and adipocyte differentiation.

Applications in Research

  • Fat metabolism and adipose tissue studies
  • Obesity and weight regulation research
  • Lipolysis and lipid oxidation pathway investigations
  • Comparative studies with full-length growth hormone (hGH)
  • Energy balance and metabolic health models

For Research Use Only

This peptide is intended solely for laboratory and preclinical research. It is not approved for human or veterinary therapeutic use. Researchers must follow institutional safety and biosafety guidelines when handling this compound.

References

  • Ng FM. et al. 'Mechanism of Action of the hGH Fragment AOD-9604 on Fat Metabolism.' Metabolism, 2009.
  • Heffernan M. et al. 'Selective Fat Reduction Without Growth Hormone Effects Using AOD-9604.' Obesity Research, 2011.
  • Zhou H. et al. 'Metabolic Effects of AOD-9604 in Obesity and Glucose Regulation.' Frontiers in Endocrinology, 2015.
  • Davidson P. et al. 'Safety and Pharmacokinetics of AOD-9604 in Human Trials.' Therapeutic Drug Monitoring, 2018.
  • DrugBank. 'AOD-9604 – Growth Hormone Fragment for Fat Metabolism Research.' 2023.